SCHEMBL4519787

SCHEMBL4519787

COc1ccccc1Cn1c(C)cc(O)c(I)c1=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MIF P14174 2/20 0.48
CD74 P04233 1/20 0.46
ALDH1A1 P00352 1/20 0.45
PRNP P04156 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 3/20 0.44
FEN1 P39748 1/20 0.44
COMT P21964 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
IDH1 O75874 1/20 0.42
MAPT P10636 2/20 0.42
PKM P14618 1/20 0.41
PDE4B Q07343 1/20 0.41
KDM4E B2RXH2 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14434463 0.87 MIF (0.50) MIFCD74ALDH1A1PRNPMEN1
SCHEMBL4514201 0.85 MIF (0.48) MIFCD74ALDH1A1PRNPMEN1
SCHEMBL13678559 0.78 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL4507491 0.77 MIF (0.54) MIFCD74PRNPMEN1KMT2A
SCHEMBL4506227 0.77 PDE1A (0.46) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL4510513 0.76 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL4510969 0.76 CMA1 (0.51) MIFCD74ALDH1A1MEN1KMT2A
SCHEMBL4499561 0.75 GAA (0.49) MIFCD74PRNPMEN1KMT2A
SCHEMBL4498127 0.73 LMNA (0.51) MIFCD74ALDH1A1PRNPMEN1
SCHEMBL15997730 0.71 NOTUM (0.63) MIFCD74ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
EP-1987022-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES Pfizer Products Inc. (US) 2008-11-05 EP disclosed
WO-2007091176-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES PFIZER PRODUCTS INC. (US) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PDXK, UMPS, CDK2 MIF 1454/4885CD74 3522/4885ALDH1A1 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.